Skip to main content

Advertisement

Fig. 1 | BMC Cancer

Fig. 1

From: Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation

Fig. 1

Kaplan-Meier curves of overall survival for the subgroups of gliomas established according to the 2007 (a) and 2016 (b) WHO classifications. a the overall survival curve of histological group (top) and the respective multivariant analysis (bottom). b The overall survival for the molecular subgroups of gliomas (top) and the respective multivariant analysis (bottom)

Back to article page